Guanhao Biotech Co.,Ltd. (SHE:300238)
China · Delayed Price · Currency is CNY 11.28
-0.11 (-0.97%)
Oct 14, 2026, 12:54 PM CST
Guanhao Biotech Market Cap
Guanhao Biotech has a market cap or net worth of 3.1 billion as of October 13, 2026. It is the 15,350th most valuable company in the world and the 4,193rd biggest in China. Its market cap has decreased by 22.92% in one year.
Market Cap
3.10B
Enterprise Value
3.00B
Revenue
361.40M
Global Rank
Country Rank
#4,193 China
PE Ratio
182.56
ChartMarket Cap Chart
Since July 6, 2011, Guanhao Biotech's market cap has increased from 2.74B to 3.10B, an increase of 12.92%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 3.10B | -15.63% |
| Dec 31, 2025 | 3.67B | 15.03% |
| Dec 31, 2024 | 3.19B | -11.21% |
| Dec 29, 2023 | 3.60B | 31.91% |
| Dec 30, 2022 | 2.73B | -44.52% |
| Dec 31, 2021 | 4.91B | -26.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xiangxue Pharmaceutical | 3.63B |
| Pulike Biological Engineering | 3.52B |
| Qingdao Vland Biotech INC. | 3.50B |
| Lifecome Biochemistry | 3.43B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Baolingbao Biology | 3.22B |
| Zhejiang East Asia Pharmaceutical | 3.18B |
| Hinova Pharmaceuticals | 3.18B |